Global CRISPR Technology Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global CRISPR Technology Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 16.5% CAGR, to an estimated market size of $10.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global CRISPR technology market includes the development, manufacturing, and application of gene-editing tools, reagents, kits, and services used to precisely modify DNA sequences. The scope covers CRISPR-Cas9 and its variants (Cas12, Cas13), as well as next-generation techniques like base editing and prime editing, applied across biomedical research, human therapeutics, agriculture, and synthetic biology.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the CRISPR Technology Market in the period 2025-30:
- The landmark FDA approval of Casgevy in late 2023 has provided critical clinical validation, accelerating investment in the therapeutic pipeline for monogenic diseases.
- Integration of Artificial Intelligence and machine learning is revolutionizing guide RNA design, significantly reducing off-target effects and improving editing precision.
- A market shift is occurring from standard CRISPR-Cas9 toward next-generation systems like base and prime editing that do not require double-strand DNA breaks.
- The democratization of gene editing through ready-to-use, off-the-shelf kits and reagents is lowering technical barriers for smaller research laboratories.
- Rising adoption in agri-biotech is focused on developing climate-resilient crops and enhancing nutritional content to address global food security challenges.
- Strategic alliances and consolidations between big pharma and specialized biotech firms are increasingly focused on solving complex delivery vehicle bottlenecks.
- Ongoing regulatory evolution and ethical debates regarding germline modification continue to shape the pace of commercialization and international market access.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Biomedical & Therapeutics
- Agriculture & Livestock
- Academic & Basic Research